Company page

Cingulate Inc.

Cingulate Inc. is a public company traded under the ticker CING in the American market. With a market capitalization of approximately $67.2 million, Cingulate focuses on developing innovative treatments for attention disorders. The company aims to improve patient outcomes through its proprietary drug formulations.